Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|November 12, 2009
Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failureHiromichi Fukushima, Naohiko Kobayashi, Hiroshi Takeshima, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 24, 2002
Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHRHideki Inada, Hidehiko Ono, Junichi Minami, et al.
International Heart Journal|July 11, 2006
Relationship between markers of inflammation and brachial-ankle pulse wave velocity in Japanese menNorikazu Andoh, Junichi Minami, Toshihiko Ishimitsu, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2023
Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertensionYoshio Iwashima, Hiromichi Fukushima, Takeshi Horio, et al.
Vascular Health and Risk Management|December 28, 2020
Comparing the Heart-Thigh and Thigh-Ankle Arteries with the Heart-Ankle Arterial Segment for Arterial Stiffness MeasurementsManami Watahiki, Shigeo Horinaka, Toshihiko Ishimitsu, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 15, 2022
Blood pressure, arterial waveform, and arterial stiffness during hemodialysis and their clinical implications in intradialytic hypotensionYoshio Iwashima, Hiromichi Fukushima, Takeshi Horio, et al.
International Heart Journal|May 17, 2013
Renoprotective effect of vasopressin v2 receptor antagonist tolvaptan in Dahl rats with end-stage heart failureMayuko Ishikawa, Naohiko Kobayashi, Fumihiro Sugiyama, et al.
Clinical and Experimental Nephrology|December 27, 2012
Renoprotective mechanisms of telmisartan on renal injury and inflammation in SHRSP.Z-Leprfa/IzmDmcr ratsFumihiro Sugiyama, Naohiko Kobayashi, Mayuko Ishikawa, et al.
Pageof 10